CMS extends deadline to comment on Medicaid, transparency rules

Jan 06, 2020 - 02:56 PM
compliance-deadline

As requested by AHA, the Centers for Medicare & Medicaid Services recently extended to Feb. 1 at 5 p.m. ET the comment deadline for its Medicaid fiscal accountability proposed rule. The original deadline was Jan. 17. The proposed rule would significantly change hospital supplemental payments and state Medicaid program financing. 
 
CMS also has extended by 15 days to Jan. 29 the deadline to submit comments on its proposed rule related to transparency in health coverage. Issued Nov. 15, the proposed rule would impose new requirements on private insurers in the individual and group markets to publicly disclose negotiated rates and out-of-network allowed amounts, and give their enrollees real-time, personalized access to cost-sharing information.

Related News Articles

Headline
Massachusetts Medicaid demonstration expands services, continuous eligibility
The Centers for Medicare & Medicaid Services April 19 approved an amendment to a Massachusetts Medicaid and Children’s Health Insurance Program…
Headline
Survey: 1 in 5 disenrolled from Medicaid since last April
One in five Medicaid enrollees have been disenrolled since continuous coverage ended last March, a quarter of whom remain uninsured, according to a poll…
Headline
CMS extends special enrollment period for persons no longer eligible for Medicaid, CHIP
The Centers for Medicare & Medicaid Services March 28 announced an extension of its temporary Marketplace special enrollment period for those who lost…
Headline
CMS issues guidance to help states make interim Medicaid payments to providers impacted by Change Healthcare attack
The Centers for Medicare & Medicaid Services March 15 announced flexibilities to help states initiate interim Medicaid payments to health care providers…
Headline
Congress passes spending package with health care extenders 
The Senate voted 75-22 on March 8 to pass and send to the president for his signature a package of six appropriations bills funding certain federal agencies…
Headline
CMS seeks sickle cell gene therapy makers to participate in Medicaid drug model 
The Centers for Medicare & Medicaid Services March 7 invited drug makers in the Medicaid Drug Rebate Program that make federally approved gene therapies…